Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

683 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.
Block G, Liss C, Reines S, Irr J, Nibbelink D. Block G, et al. Eur Neurol. 1997;37(1):23-7. doi: 10.1159/000117399. Eur Neurol. 1997. PMID: 9018028 Clinical Trial.
An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients.
Olanow CW, Nakano K, Nausieda P, Tetrud JA, Manyam B, Last B, Block G, Liss C, Bush D. Olanow CW, et al. Among authors: block g. Clin Neuropharmacol. 1991 Jun;14(3):235-40. doi: 10.1097/00002826-199106000-00006. Clin Neuropharmacol. 1991. PMID: 2070363 Clinical Trial.
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study.
Koller WC, Block GA, Ahlskog JE, Ahrens S, Cedarbaum JM, Cyhan G, Goetz CG, LeWitt PA, Liss C, McLean L, et al. Koller WC, et al. Among authors: block ga. Clin Neuropharmacol. 1991 Aug;14(4):322-9. doi: 10.1097/00002826-199108000-00004. Clin Neuropharmacol. 1991. PMID: 1913699 Clinical Trial.
Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patients.
Hammerstad JP, Woodward WR, Nutt JG, Gancher ST, Block GA, Cyhan G. Hammerstad JP, et al. Among authors: block ga. Clin Neuropharmacol. 1994 Oct;17(5):429-34. doi: 10.1097/00002826-199410000-00005. Clin Neuropharmacol. 1994. PMID: 9316692 Clinical Trial.
Poor tolerability of MK-458.
Cutler NR, Sramek JJ, Block GA. Cutler NR, et al. Among authors: block ga. Arch Neurol. 1993 Sep;50(9):896. doi: 10.1001/archneur.1993.00540090007003. Arch Neurol. 1993. PMID: 8363442 No abstract available.
Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism.
Sterrett JR, Strom J, Stummvoll HK, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA. Sterrett JR, et al. Among authors: block ga. Clin Nephrol. 2007 Jul;68(1):10-7. doi: 10.5414/cnp68010. Clin Nephrol. 2007. PMID: 17703830 Clinical Trial.
Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.
Prahalada S, Block G, Handt L, DeBurlet G, Cahill M, Hoe CM, van Zwieten MJ. Prahalada S, et al. Among authors: block g. Horm Metab Res. 1999 Feb-Mar;31(2-3):133-7. doi: 10.1055/s-2007-978710. Horm Metab Res. 1999. PMID: 10226793
A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
Delmez J, Block G, Robertson J, Chasan-Taber S, Blair A, Dillon M, Bleyer AJ. Delmez J, et al. Among authors: block g. Clin Nephrol. 2007 Dec;68(6):386-91. doi: 10.5414/cnp68386. Clin Nephrol. 2007. PMID: 18184521 Clinical Trial.
Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients.
Block GA. Block GA. Clin Nephrol. 2000 Oct;54(4):318-24. Clin Nephrol. 2000. PMID: 11076108 Review.
Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.
Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ. Wetmore JB, et al. Among authors: block ga. Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19. Nephrol Dial Transplant. 2016. PMID: 26292694
683 results
Jump to page